ONVO 1 (-2.91%)
US68620A2033Medical Diagnostics & ResearchDiagnostics & Research

Organovo Holdings (ONVO) Competitor Comparison

We are evaluating the key criteria listed to compare Organovo Holdings (ONVO) against its competitors in the Diagnostics & Research industry.

Performance 5 years - ONVO ranking 56 / 58

These are the competitors of Organovo Holdings in the industry Diagnostics & Research ranked by performance 5 years
1. Medpace Holdings MEDP
590.04
2. Natera NTRA
360.23
3. DexCom DXCM
359.76
4. RadNet RDNT
281
5. Fulgent Genetics FLGT
201.63
6. Lantheus Holdings LNTH
166.54
7. Icon ICLR
120.9
8. IDEXX Laboratories IDXX
119.7
9. Meridian Bioscience VIVO
118.46
10. Inotiv NOTV
117.09
11. Thermo Fisher Scientific TMO
109.53
12. Danaher DHR
87.61
13. Agilent Technologies A
74.81
14. IQVIA Holdings IQV
71.68
15. Charles River Laboratories CRL
68.3
16. Mettler-Toledo MTD
64.42
17. Laboratory Corp of America Holdings LH
61.49
18. SeqLL SQL
59.42
19. DarioHealth DRIO
58.9
20. Quest Diagnostics DGX
50.31
21. PerkinElmer PKI
48.44
22. Waters WAT
22.84
23. Ortho Clinical Diagnostics Holdings OCDX
13.74
24. Heska HSKA
12.14
25. Co-Diagnostics CODX
11.65
26. Qiagen QGEN
4.49
27. Twist Bioscience TWST
-7.57
28. National Research NRC
-12.5
29. Syneos Health SYNH
-16.98
30. Anixa Biosciences ANIX
-24.64
31. NeoGenomics NEO
-30.83
32. Exact Sciences EXAS
-33.74
33. Sera Prognostics SERA
-35.04
34. Trinity Biotech TRIB
-38.44
35. Olink Holding OLK
-38.64
36. Myriad Genetics MYGN
-42.15
37. Neogen NEOG
-58.89
38. Sotera Health SHC
-59.44
39. Illumina ILMN
-63.14
40. bioAffinity Technologies BIAF
-66.9
41. CareDx CDNA
-68.65
42. Enzo Biochem ENZ
-69.55
43. Bioventus BVS
-70.33
44. Neuronetics STIM
-75.26
45. MaxCyte MXCT
-76.75
46. Guardant Health GH
-76.76
47. Pacific Biosciences of California PACB
-78.88
48. Interpace Biosciences IDXG
-79.26
49. Psychemedics PMD
-81.59
50. MDxHealth MDXH
-81.65
51. Aspira Womens Health AWH
-82.51
52. Global Cord Blood CO
-86.47
53. Biodesix BDSX
-90.8
54. Exagen XGN
-91.85
55. Personalis PSNL
-94.53
56. Organovo Holdings ONVO
-94.61
57. Precipio PRPO
-96.21
58. Prenetics Global PRE
-97.58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.